Elia Seguí

1.2k citations
46 papers · 838 · h-index 15

Impact in

  • Oncology top 5%
    • COVID-19 and healthcare impacts
    • Cancer Immunotherapy and Biomarkers
    • HER2/EGFR in Cancer Research
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 and COVID-19 Research

Papers in

    • COVID-19 and healthcare impacts 12
    • Cancer Immunotherapy and Biomarkers 8
    • Inflammatory Biomarkers in Disease Prognosis 3
    • Breast Cancer Treatment Studies 12

Elia Seguí

43 papers receiving 828 citations

Peers

Elia Seguí
Comparison fields: 5 of 56
  • Oncology 454
  • Infectious Diseases 230
  • Cancer Research 92
  • Neurology 68
  • Internal Medicine 9
Replace Roxana Reyes with:
Roxana Reyes Spain
Myria Galazi United Kingdom
David García-Illescas Spain
Lisa May Ling Tachiki United States
Joanne S. Evans United Kingdom
Johan Pluvy France
Javier Baena Espinar Spain
Ali Abdulnabi Suwaidan United Kingdom
Hayley McKenzie United Kingdom
Francesca Holt United Kingdom
Elia Seguí relative to Roxana Reyes Spain Roxana Reyes's profile →
Citations per field
00.5×2×3×3.8×
Roxana Reyes · 1×
Citations per year

Countries citing papers authored by Elia Seguí

Since Specialization
Citations

This map shows the geographic impact of Elia Seguí's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elia Seguí with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elia Seguí more than expected).

Fields of papers citing papers by Elia Seguí

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elia Seguí. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elia Seguí. The network helps show where Elia Seguí may publish in the future.

Co-authors

The 25 scholars most cited alongside Elia Seguí, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elia Seguí Line = papers co-authored together Elia Seguí links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2020153
2 202192
3 201885
4 202267
5 202160
6 202053
7 202142
8 202130
9 202228
10 202325
11 202221
12 202217
13 202417
14 202116
15 202416
16 202415
17 202313
18 20229
19 20259
20 20207

About Elia Seguí

Elia Seguí is a scholar working on Oncology, Cancer Research, Infectious Diseases, Pulmonary and Respiratory Medicine and Neurology, having authored 46 papers that have together received 838 indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (12 papers), Breast Cancer Treatment Studies (12 papers), Cancer Immunotherapy and Biomarkers (8 papers), COVID-19 Clinical Research Studies (5 papers), Advanced Breast Cancer Therapies (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Long-Term Effects of COVID-19 (2 papers) and BRCA gene mutations in cancer (2 papers). The work is most often cited by research in Oncology (454 citations), Infectious Diseases (230 citations), Cancer Research (92 citations), Neurology (68 citations) and Internal Medicine (9 citations). Elia Seguí has collaborated with scholars based in Spain, Italy and United Kingdom. Frequent co-authors include Francesco Schettini, Aleix Prat, Alba Di Leone, Luisa Carbognin, Giampaolo Tortora, Antonio Franco, Núria Chic, Giovanna Garufi, Joan Padrosa and Giovanni Scambia. Their work appears in journals such as ESMO Open, Annals of Oncology, The Lancet Oncology, European Journal of Cancer and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact